Company / Inventory
IOVANCE BIOTHERAPEUTICS, INC. Inventory History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$51.7M
FY2025
5-year range
$10.4M / $51.7M
FY2023-FY2025
Trend
+0.3%
vs FY2024
Sector context
#56 of 105
Health Care
What the data says
At $52M, IOVANCE BIOTHERAPEUTICS, INC.'s inventory ranks #56 of 105 in the Health Care sector. Improved from $10M to $52M over the past 2 years.
Based on SEC 10-K filings.
$52M in FY2025.
Improved from $10M to $52M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 105 in Health CareTop 53% of 105This company $51.7M Sector average $885.3M
▼
-94.2% below sector average
Key checks
Key Insights
- In FY2025, inventory increased 0.3% year-over-year.
- Ranks #56 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.7M | +0.3% |
| FY2024 | $51.5M | +396.7% |
| FY2023 | $10.4M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026